SCHEMBL6864455

SCHEMBL6864455

CC(=O)CCCC(=O)NS(=O)(=O)c1ccccc1NC(=O)c1ccccc1C#Cc1ccc(OC(F)(F)F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 2/20 0.38
FFAR1 O14842 3/20 0.36
HDAC3 O15379 1/20 0.36
HDAC1 Q13547 1/20 0.36
SLC16A3 O15427 1/20 0.34
MMP2 P08253 2/20 0.34
MMP1 P03956 1/20 0.34
MMP9 P14780 1/20 0.34
MMP14 P50281 1/20 0.34
ADAM17 P78536 1/20 0.34
MAPT P10636 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HTT P42858 2/20 0.33
KDM4E B2RXH2 1/20 0.33
KMT2A Q03164 1/20 0.33
MMP13 P45452 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6864851 0.92 HDAC3 (0.38) ACACBFFAR1HDAC3HDAC1SLC16A3
SCHEMBL6864874 0.89 RXFP1 (0.37) ACACBFFAR1HDAC3HDAC1ALDH1A1
SCHEMBL6866204 0.88 FFAR1 (0.38) FFAR1HDAC3HDAC1SLC16A3ALDH1A1
SCHEMBL6866219 0.81 RXFP1 (0.43) HDAC3HDAC1MAPTALDH1A1
SCHEMBL6860565 0.81 CA2 (0.45) ACACBFFAR1
SCHEMBL6860195 0.79 TSHR (0.38) FFAR1HDAC3HDAC1ALDH1A1KDM4E
SCHEMBL6864872 0.76 PTGES (0.37) FFAR1HDAC1SLC16A3MAPTALDH1A1
SCHEMBL6860345 0.74 KCNA5 (0.35) KDM4E
SCHEMBL38665719 0.71 POLB (0.52) SLC16A3MMP2MMP1MMP9MMP14
SCHEMBL6536443 0.71 RXFP1 (0.39) HDAC3HDAC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6812252-B2 ACYLSULFONAMIDE DERIVATIVES CONTAINING FLUOROSUBSTITUTEDPHENYLETHYNYL GROUP HAVING A HYPOGLYCEMIC EFFECT AND FREE OF THE SIDE EFFECT AJINOMOTO CO., INC. (JP) 2004-11-02 US disclosed
US-20030181764-A1 Acylsulfonamide derivatives AJINOMOTO CO. INC (JP) 2003-09-25 US disclosed
EP-1316548-A1 ACYLSULFONAMIDE DERIVATIVES Ajinomoto Co., Inc. (JP) 2003-06-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030181764-A1 Acylsulfonamide derivatives DPP4, SLC5A2, GLP1R ACACB 45/4885FFAR1 83/4885HDAC3 33/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.